Bioharvest Sciences Ratios (2023-2025) | BHST

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 40.22%44.52%50.73%56.19%51.47%56.80%56.65%58.46%59.73%61.43%57.63%
EBT Margin (Quarter) 103.64%53.32%-395.86%-123.15%-11.40%-41.12%-40.51%-29.26%-47.46%-27.02%-25.02%
EBIT Margin (Quarter) 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%-12.36%
EBITDA Margin (Quarter) -104.55%-61.96%-384.58%-26.65%-29.47%-32.15%-23.18%21.87%-21.32%-10.15%-12.36%
Operating Margin (Quarter) 104.55%61.96%-384.58%-26.65%-29.47%-32.15%-23.18%-21.87%-21.32%-10.15%-12.36%
Net Margin (Quarter) 103.64%53.32%-395.86%-123.15%-11.40%-41.12%-40.51%-29.75%-47.92%-27.72%-22.63%
FCF Margin (Quarter) -17.13%-59.80%-25.37%12.44%-19.07%-105.33%-9.45%-10.15%-18.37%-69.58%
Efficiency
Inventory Average (Quarter) 3.06M3.11M2.88M3.42M3.83M4.07M4.28M4.50M
Assets Average (Quarter) 26.42M25.41M25.80M27.19M31.49M41.43M
Invested Capital (Quarter) 20.53M3.90M0.15M
Asset Utilization Ratio (Quarter) 0.850.991.071.111.040.83
Leverage & Solvency
Interest Coverage Ratio (Quarter) 18.0812.9517.58-0.28-4.70-3.58-1.34-2.96-0.82-0.60-0.93
Debt Ratio (Quarter) 1.370.160.00
Times Interest Earned (Quarter) 18.0812.9517.58-0.28-4.70-3.58-1.34-2.96-0.82-0.60-0.93
Valuation
Enterprise Value (Quarter) -5.53M-2.76M-5.57M-3.13M-2.76M-3.76M-4.12M-11.37M-23.02M
Return Ratios
Return on Sales (Quarter) 0.01%0.01%-0.04%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -137.57%-62.66%-106.13%-72.58%-33.55%-16.52%
Return on Invested Capital (Quarter) -0.03%
Return on Assets (Quarter) -0.01%-0.01%0.00%0.00%0.00%0.00%